You searched for "binocular"
Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)
3 April 2023
| Li Yen Goh
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...
The Case of Dr Bawa-Garba – Where does the buck stop?
The case of Hadiza Bawa-Garba has left all of us in the UK medical profession with an uncomfortable taste in our mouths. We all know that we work under pressure and we will inevitably make mistakes. We all know that...Diabetic retinopathy screening in Belize: a country’s journey towards reducing blindness from DR
1 February 2019
| Covadonga Bascaran, Ellen Heinemann, Carla Ayres Musa, Donovan Cacho, Andrew Smith
|
EYE - Vitreo-Retinal, EYE - General
The rise of diabetes mellitus (DM) and its complications is a public health concern in the Caribbean. The Caribbean Diabetic Retinopathy (DR) Programme, managed by the London School of Hygiene & Tropical Medicine (LSHTM) and funded by the Queen Elizabeth...
Survey of current undergraduate ophthalmology teaching in the United Kingdom
1 October 2019
| Farihah Tariq, Mohamad Loutfi, Nazim Ghouri, Mark Watts
Is there a crisis in ophthalmic education? The British Undergraduate Ophthalmology Society surveyed medical students and junior doctors to evaluate current ophthalmology teaching across medical schools in the UK. British medicals schools are currently not obligated to include ophthalmology within...
Learnings and trends in the management of open-angle and angle-closure glaucoma
1 August 2017
| Winifred Nolan, Nick Strouthidis, Keith Barton
|
EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...
Strategies for managing neovascular AMD and DMO in routine clinical care
1 October 2015
| Rod McNeil
|
EYE - Vitreo-Retinal
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...
Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup
1 February 2015
| B Karri, RT Sebastian, G Kyle, IK Hart
|
EYE - Vitreo-Retinal
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...
NICE drugs: an update on what’s good to go
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...Quality matters in the management of serious eye disorders
1 June 2019
| Rod McNeil
|
EYE - Cataract, EYE - Glaucoma, EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...
Effective management of dry eye and ocular surface disease
4 August 2021
| Rod McNeil
|
EYE - General
Experts recommend a consistent approach to diagnosis, therapeutic targeting by disease subtype and escalation of therapy when tear substitutes are not sufficient. Experts call for a consistent, unified approach to diagnosis of dry eye disease (DED), with a new simple...
Broadening of treatment options for potentially blinding retinal conditions
2 August 2022
| Rod McNeil
|
EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
Impact of Eye Health Surveys and Partnerships in The Gambia
4 October 2023
| Hannah Faal, Abba Hydara, Islay Mactaggart, Matthew Burton, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
This article brings together the three national eye health surveys that have been undertaken in The Gambia between 1986 and 2019 and the impact that the results have had nationally and internationally. In it we describe the long-term capacity-strengthening for...
